Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

3.5K
3.5K
RNA Interference01:23

RNA Interference

25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A curated reference database of membrane-permeability annotations for biological dyes.

Scientific data·2026
Same author

Copper-Iron Cell Death Axis: Mechanistic Crosstalk, Disease Implications and an Integrated Metallo-Redox-Metabolic Framework.

International journal of biological sciences·2026
Same author

Emerging concept of precise neuromodulation: Genetics-based neuromodulation in spinal cord injury.

Neural regeneration research·2026
Same author

Rethinking bioinformatics in liquid-liquid phase separation: data resources, predictive models, and an event-centric perspective.

Briefings in bioinformatics·2026
Same author

Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms.

Neural regeneration research·2026
Same author

Immuno-PET/CT Imaging of Trop2 Expression with [<sup>18</sup>F]AlF-RESCA-RT4 Enhances Diagnosis of Breast Cancers and the Metastases.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Related Experiment Video

Updated: Jun 7, 2025

MISSION esiRNA for RNAi Screening in Mammalian Cells
15:31

MISSION esiRNA for RNAi Screening in Mammalian Cells

Published on: May 12, 2010

16.3K

siRNAEfficacyDB: An experimentally supported small interfering RNA efficacy database.

Yang Zhang1, Ting Yang2, Yu Yang2

  • 1Innovative Institute of Chinese Medicine and Pharmacy, Academy for Interdiscipline, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

IET Systems Biology
|November 14, 2024
PubMed
Summary

A new database, siRNAEfficacyDB, offers validated data on small interfering RNA (siRNA) efficacy for 3544 records. This resource aids in optimizing siRNA drug design and advancing nucleic acid therapeutics.

Keywords:
RNAbig datadrugs

More Related Videos

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools
00:09

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools

Published on: August 21, 2019

7.3K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K

Related Experiment Videos

Last Updated: Jun 7, 2025

MISSION esiRNA for RNAi Screening in Mammalian Cells
15:31

MISSION esiRNA for RNAi Screening in Mammalian Cells

Published on: May 12, 2010

16.3K
A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools
00:09

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools

Published on: August 21, 2019

7.3K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Bioinformatics

Background:

  • Small interfering RNA (siRNA) technology enables precise gene silencing for biomedical research and drug development.
  • Current challenges in siRNA therapy include delivery efficiency, target specificity, and molecular stability.
  • Overcoming these hurdles is crucial for advancing siRNA-based therapeutics.

Purpose of the Study:

  • To develop siRNAEfficacyDB, a comprehensive database of experimentally validated siRNA efficacy data.
  • To provide a centralized resource for researchers involved in siRNA drug design and development.
  • To facilitate computer-aided siRNA design and nucleic acid drug discovery.

Main Methods:

  • Compilation of 3544 siRNA records from experimental studies.
  • Integration of data including siRNA sequences, target genes, inhibition efficiencies, and experimental conditions.
  • Development of a user-friendly web interface for data querying, browsing, and analysis.

Main Results:

  • The database covers 42 target genes and 5 cell lines.
  • Detailed information on siRNA sequences, target genes, inhibition efficiencies, experimental techniques, cell lines, concentrations, and incubation times is included.
  • The web interface allows for efficient data access and analysis.

Conclusions:

  • siRNAEfficacyDB serves as a valuable data foundation for siRNA drug design and optimization.
  • The database supports advancements in computer-aided siRNA design research.
  • It is a crucial resource for the development of nucleic acid-based drugs.